{"id":42992,"date":"2020-04-01T08:06:31","date_gmt":"2020-04-01T12:06:31","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=42992"},"modified":"2020-04-01T02:10:08","modified_gmt":"2020-04-01T06:10:08","slug":"johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992","title":{"rendered":"Johnson &#038; Johnson (NYSE:JNJ) Expects To Deliver Over 1 Billion Doses Of Vaccine For COVID-19 And Commence Clinical Trials By September 2020"},"content":{"rendered":"<p><strong>Johnson &amp; Johnson (NYSE:JNJ) <\/strong>has decided to produce over 1 billion doses of vaccine for COVID-19 by teaming up with the Biomedical Advanced Research and Development Authority (BARDA)\u00a0in the US. It is an extension of the existing accord between the Janssen Pharmaceutical Companies division of Johnson &amp; Johnson and BARDA.<\/p>\n<p><strong>The first batch of affordable vaccines by early 2021<\/strong><\/p>\n<p>Johnson &amp; Johnson expects to release the first batch of vaccines for emergency use by early 2021. The company will engage in R&amp;D of potential antiviral treatments in alliance with BARDA besides developing an economical vaccine for the coronavirus disease. They are also engaged in developing vaccines in Belgium in partnership with Rega Institute for Medical Research.<\/p>\n<p><strong>Expands production capacity worldwide<\/strong><\/p>\n<p>Johnson &amp; Johnson decided to expand the manufacturing capacity in the US and across the world. This initiative helps the company to produce vaccines on a large scale to provide to the general public to get rid of the COVID-19 pandemic.<\/p>\n<p>Janssen Pharmaceutical already began the research in January this year together with the teams of Beth Israel Deaconess Medical Center to find potential vaccine candidates. They have already tested these vaccine candidates at many academic institutions. It helped to identify a lead vaccine candidate for COVID-19 along with two potential backups.<\/p>\n<p>Another pharmaceutical company \u2013 Modema Health last week said it is working on a potential vaccine and expect to release a trial version this fall for the healthcare workers. The company uses messenger RNA in its vaccine to inoculate against coronavirus. However, it doesn\u2019t expose the recipients to the dangerous coronavirus. They will not contract the disease during the treatment. Modema Health last week conducted a phase 1 clinical trial using the new vaccine on volunteers in Washington.<\/p>\n<p><strong>Small startups and drug makers step up efforts<\/strong><\/p>\n<p>Several startups and drug makers have stepped up efforts to develop a vaccine for coronavirus. BioNTech, a company based in Germany, and Pfizer, a US-based drugmaker, have agreed to develop a vaccine for COVID-19 jointly. They will finalize the development and manufacturing terms and commercialization details in the next few weeks. On Monday, BioNTech signed a deal with Shanghai Fosun Pharmaceutical to commence clinical trials on humans in China.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Johnson &amp; Johnson (NYSE:JNJ) has decided to produce over 1 billion doses of vaccine for COVID-19 by teaming up with the Biomedical Advanced Research and [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":42993,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[14288,3420,1744,995],"stock_ticker":[14213],"class_list":["post-42992","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-covid-19-pandemic","tag-johnson-johnson","tag-johnson-johnson-nysejnj","tag-nysejnj","stock_ticker-jnj","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Johnson &amp; Johnson (NYSE:JNJ) Expects To Deliver Over 1 Billion Doses Of Vaccine For COVID-19 And Commence Clinical Trials By September 2020 - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Johnson &amp; Johnson (NYSE:JNJ) Expects To Deliver Over 1 Billion Doses Of Vaccine For COVID-19 And Commence Clinical Trials By September 2020 - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Johnson &amp; Johnson (NYSE:JNJ) has decided to produce over 1 billion doses of vaccine for COVID-19 by teaming up with the Biomedical Advanced Research and [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-01T12:06:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/04\/COVID-19-john.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Benjamin Roussey\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benjamin Roussey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992\"},\"author\":{\"name\":\"Benjamin Roussey\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\"},\"headline\":\"Johnson &#038; Johnson (NYSE:JNJ) Expects To Deliver Over 1 Billion Doses Of Vaccine For COVID-19 And Commence Clinical Trials By September 2020\",\"datePublished\":\"2020-04-01T12:06:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992\"},\"wordCount\":387,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/04\/COVID-19-john.jpg\",\"keywords\":[\"COVID-19 pandemic\",\"Johnson &amp; Johnson\",\"Johnson &amp; Johnson (NYSE:JNJ)\",\"NYSE:JNJ\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992\",\"name\":\"Johnson & Johnson (NYSE:JNJ) Expects To Deliver Over 1 Billion Doses Of Vaccine For COVID-19 And Commence Clinical Trials By September 2020 - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/04\/COVID-19-john.jpg\",\"datePublished\":\"2020-04-01T12:06:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/04\/COVID-19-john.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/04\/COVID-19-john.jpg\",\"width\":2560,\"height\":1440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Johnson &#038; Johnson (NYSE:JNJ) Expects To Deliver Over 1 Billion Doses Of Vaccine For COVID-19 And Commence Clinical Trials By September 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\",\"name\":\"Benjamin Roussey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"caption\":\"Benjamin Roussey\"},\"description\":\"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Johnson & Johnson (NYSE:JNJ) Expects To Deliver Over 1 Billion Doses Of Vaccine For COVID-19 And Commence Clinical Trials By September 2020 - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992","og_locale":"en_US","og_type":"article","og_title":"Johnson & Johnson (NYSE:JNJ) Expects To Deliver Over 1 Billion Doses Of Vaccine For COVID-19 And Commence Clinical Trials By September 2020 - Wall Street PR","og_description":"Johnson &amp; Johnson (NYSE:JNJ) has decided to produce over 1 billion doses of vaccine for COVID-19 by teaming up with the Biomedical Advanced Research and [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2020-04-01T12:06:31+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/04\/COVID-19-john.jpg","type":"image\/jpeg"}],"author":"Benjamin Roussey","twitter_misc":{"Written by":"Benjamin Roussey","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992"},"author":{"name":"Benjamin Roussey","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d"},"headline":"Johnson &#038; Johnson (NYSE:JNJ) Expects To Deliver Over 1 Billion Doses Of Vaccine For COVID-19 And Commence Clinical Trials By September 2020","datePublished":"2020-04-01T12:06:31+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992"},"wordCount":387,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/04\/COVID-19-john.jpg","keywords":["COVID-19 pandemic","Johnson &amp; Johnson","Johnson &amp; Johnson (NYSE:JNJ)","NYSE:JNJ"],"articleSection":["Health"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992","url":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992","name":"Johnson & Johnson (NYSE:JNJ) Expects To Deliver Over 1 Billion Doses Of Vaccine For COVID-19 And Commence Clinical Trials By September 2020 - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/04\/COVID-19-john.jpg","datePublished":"2020-04-01T12:06:31+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/04\/COVID-19-john.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/04\/COVID-19-john.jpg","width":2560,"height":1440},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-expects-to-deliver-over-1-billion-doses-of-vaccine-for-covid-19-and-commence-clinical-trials-by-september-2020-42992#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Johnson &#038; Johnson (NYSE:JNJ) Expects To Deliver Over 1 Billion Doses Of Vaccine For COVID-19 And Commence Clinical Trials By September 2020"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d","name":"Benjamin Roussey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","caption":"Benjamin Roussey"},"description":"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/42992","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=42992"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/42992\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/42993"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=42992"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=42992"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=42992"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=42992"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}